Sign in
4

Changes in Ownership

REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-24-000106

EVP Commercial sold 1,137 shares at $1,047.11 ($1,190,564)

  • EVP Commercial acquired 1,137 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

McCourt Marion · EVP Commercial

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-07-01 Exercise or conversion : show line 1 in the form 10b5-1 +1,137 $372.46 $423,487 14,068 D
2024-07-01 Sale : show line 2 in the form 10b5-1 −1,137 $1,047.11 $1,190,564 12,931 D
Open-market sales · 1,137 sh · avg $1,047.11 · $1,190,564

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-07-01 Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −1,137 1,137 D
Loading xslF345X05/edgardoc.xml…